Department of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.
Department of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.
Vaccine. 2022 Jan 3;40(1):122-132. doi: 10.1016/j.vaccine.2021.11.026. Epub 2021 Nov 15.
Little is known about COVID-19 vaccination intent among people experiencing homelessness. This study assesses surveyed COVID-19 vaccination intent among adult homeless shelter residents and staff and identifies factors associated with vaccine deliberation (responded "undecided") and reluctance (responded "no"), including time trends.
From 11/1/2020-2/28/21, we conducted repeated cross-sectional surveys at nine shelters in King County, WA as part of ongoing community-based SARS-CoV-2 surveillance. We used a multinomial model to identify characteristics associated with vaccine deliberation and reluctance.
A total of 969 unique staff (n = 297) and residents (n = 672) participated and provided 3966 survey responses. Among residents, 53.7% (n = 361) were vaccine accepting, 28.1% reluctant, 17.6% deliberative, and 0.6% already vaccinated, whereas among staff 56.2% were vaccine accepting, 14.1% were reluctant, 16.5% were deliberative, and 13.1% already vaccinated at their last survey. We observed higher odds of vaccine deliberation or reluctance among Black/African American individuals, those who did not receive a seasonal influenza vaccine, and those with lower educational attainment. There was no significant trend towards vaccine acceptance.
Strong disparities in vaccine intent based on race, education, and prior vaccine history were observed. Increased vaccine intent over the study period was not detected. An intersectional, person-centered approach to addressing health inequities by public health authorities planning vaccination campaigns in shelters is recommended. Clinical Trial Registry Number: NCT04141917.
对于无家可归者群体中对 COVID-19 疫苗接种的意向知之甚少。本研究评估了成年收容所居民和工作人员中 COVID-19 疫苗接种意向,确定了与疫苗审议(表示“未决定”)和不愿接种(表示“否”)相关的因素,包括时间趋势。
2020 年 11 月 1 日至 2021 年 2 月 28 日,我们在华盛顿州金县的九个收容所进行了重复的横断面调查,作为正在进行的基于社区的 SARS-CoV-2 监测的一部分。我们使用多项模型来确定与疫苗审议和不情愿相关的特征。
共有 969 名工作人员(n=297)和居民(n=672)参与并提供了 3966 份调查答复。在居民中,53.7%(n=361)接受疫苗接种,28.1%不愿意,17.6%审议,0.6%已接种疫苗,而在工作人员中,56.2%接受疫苗接种,14.1%不愿意,16.5%审议,13.1%在上一次调查时已接种疫苗。我们观察到,黑人/非裔美国人、未接种季节性流感疫苗的人以及教育程度较低的人,疫苗审议或不情愿的可能性更高。疫苗接受率没有明显的趋势。
根据种族、教育和先前疫苗接种史,疫苗接种意向存在明显差异。在研究期间,疫苗接种意向没有增加。建议公共卫生当局在规划收容所疫苗接种活动时,采用交叉的、以个人为中心的方法来解决健康不平等问题。临床试验注册号:NCT04141917。